Logo image of OIIM

O2MICRO INTERNATIONAL-ADR (OIIM) Stock Fundamental Analysis

NASDAQ:OIIM - Nasdaq - US67107W1009 - ADR - Currency: USD

4.9  0 (0%)

After market: 4.91 +0.01 (+0.2%)

Fundamental Rating

4

OIIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for OIIM as it has an excellent financial health rating, but there are worries on the profitability. OIIM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

OIIM had positive earnings in the past year.
OIIM Yearly Net Income VS EBIT VS OCF VS FCFOIIM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M -20M

1.2 Ratios

OIIM has a Return On Assets (6.72%) which is comparable to the rest of the industry.
OIIM has a Return On Equity (7.85%) which is comparable to the rest of the industry.
The Return On Invested Capital of OIIM (6.52%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 6.72%
ROE 7.85%
ROIC 6.52%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OIIM Yearly ROA, ROE, ROICOIIM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 -20

1.3 Margins

OIIM's Profit Margin of 8.33% is in line compared to the rest of the industry. OIIM outperforms 45.19% of its industry peers.
OIIM's Profit Margin has improved in the last couple of years.
OIIM has a Operating Margin (7.88%) which is comparable to the rest of the industry.
The Gross Margin of OIIM (52.86%) is better than 63.46% of its industry peers.
OIIM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.88%
PM (TTM) 8.33%
GM 52.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y52.94%
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y0.28%
OIIM Yearly Profit, Operating, Gross MarginsOIIM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

8

2. Health

2.1 Basic Checks

OIIM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OIIM has more shares outstanding than it did 1 year ago.
OIIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OIIM Yearly Shares OutstandingOIIM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
OIIM Yearly Total Debt VS Total AssetsOIIM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 6.43 indicates that OIIM is not in any danger for bankruptcy at the moment.
The Altman-Z score of OIIM (6.43) is better than 73.08% of its industry peers.
OIIM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.43
ROIC/WACC0.57
WACC11.41%
OIIM Yearly LT Debt VS Equity VS FCFOIIM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M

2.3 Liquidity

OIIM has a Current Ratio of 6.20. This indicates that OIIM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.20, OIIM belongs to the best of the industry, outperforming 82.69% of the companies in the same industry.
OIIM has a Quick Ratio of 4.72. This indicates that OIIM is financially healthy and has no problem in meeting its short term obligations.
OIIM has a better Quick ratio (4.72) than 79.81% of its industry peers.
Industry RankSector Rank
Current Ratio 6.2
Quick Ratio 4.72
OIIM Yearly Current Assets VS Current LiabilitesOIIM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OIIM have decreased strongly by -38.10% in the last year.
The Earnings Per Share has been growing by 69.56% on average over the past years. This is a very strong growth
OIIM shows a small growth in Revenue. In the last year, the Revenue has grown by 0.45%.
OIIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.30% yearly.
EPS 1Y (TTM)-38.1%
EPS 3Y69.56%
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y17.26%
Revenue growth 5Y12.3%
Sales Q2Q%-15.83%

3.2 Future

Based on estimates for the next years, OIIM will show a very negative growth in Earnings Per Share. The EPS will decrease by -69.74% on average per year.
The Revenue is expected to decrease by -8.29% on average over the next years.
EPS Next Y-106.54%
EPS Next 2Y-69.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-21.26%
Revenue Next 2Y-8.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OIIM Yearly Revenue VS EstimatesOIIM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
OIIM Yearly EPS VS EstimatesOIIM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 0.2 -0.2 -0.4 -0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.85, OIIM is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as OIIM.
OIIM is valuated rather cheaply when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 137.25 indicates a quite expensive valuation of OIIM.
OIIM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. OIIM is more expensive than 67.31% of the companies in the same industry.
OIIM is valuated expensively when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.85
Fwd PE 137.25
OIIM Price Earnings VS Forward Price EarningsOIIM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

89.42% of the companies in the same industry are more expensive than OIIM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.04
OIIM Per share dataOIIM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as OIIM's earnings are expected to decrease with -69.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-69.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OIIM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

O2MICRO INTERNATIONAL-ADR

NASDAQ:OIIM (3/2/2023, 8:23:51 PM)

After market: 4.91 +0.01 (+0.2%)

4.9

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-02 2023-02-02
Earnings (Next)05-04 2023-05-04
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap143.02M
Analysts43.33
Price Target4.9 (0%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)400.43%
Min EPS beat(2)17.62%
Max EPS beat(2)783.24%
EPS beat(4)4
Avg EPS beat(4)226.89%
Min EPS beat(4)17.62%
Max EPS beat(4)783.24%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.14%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)0.32%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.74%
Max Revenue beat(4)0.32%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-73.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.26%
EPS NY rev (3m)31.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 18.85
Fwd PE 137.25
P/S 1.5
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.41
EV/EBITDA 6.04
EPS(TTM)0.26
EY5.31%
EPS(NY)0.04
Fwd EY0.73%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.27
BVpS3.47
TBVpS3.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.72%
ROE 7.85%
ROCE N/A
ROIC 6.52%
ROICexc 12.46%
ROICexgc 12.46%
OM 7.88%
PM (TTM) 8.33%
GM 52.86%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y52.94%
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.2
Quick Ratio 4.72
Altman-Z 6.43
F-Score4
WACC11.41%
ROIC/WACC0.57
Cap/Depr(3y)124.36%
Cap/Depr(5y)98.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.1%
EPS 3Y69.56%
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y-106.54%
EPS Next 2Y-69.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.45%
Revenue growth 3Y17.26%
Revenue growth 5Y12.3%
Sales Q2Q%-15.83%
Revenue Next Year-21.26%
Revenue Next 2Y-8.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-35.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1488.53%
OCF growth 3YN/A
OCF growth 5YN/A